Sign In
Buy CAR
$173.86
+1.48 (+0.86%)
At Close: Jun 03, 2026
SOMERSET, N.J., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced new long-term clinical and translational
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL
37,421 Shares in Avis Budget Group, Inc. $CAR Acquired by Franklin Resources Inc.
04:20am, Monday, 01'st Dec 2025
Franklin Resources Inc. acquired a new stake in Avis Budget Group, Inc. (NASDAQ: CAR) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquir
Why Is Avis Budget (CAR) Down 8% Since Last Earnings Report?
12:31pm, Wednesday, 26'th Nov 2025
Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma.
BROAD ARROW ANNOUNCES, “GLOBAL ICONS,” AN ONLINE COLLECTOR CAR AND MEMORABILIA SALE SCHEDULED FOR JANUARY 2026
04:30am, Thursday, 20'th Nov 2025
NOVEL THREE-PART ONLINE AUCTION TO INCLUDE EUROPE AND UK-BASED COLLECTOR CARS ALONGSIDE MOTORSPORT MEMORABILIA | HIGHLY ORIGINAL 1971 LAMBORGHINI MIURA P400 S LEADS EARLY COLLECTOR CAR HIGHLIGHTS | LI
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027
09:00am, Wednesday, 19'th Nov 2025
All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR ⍺ Antagonist, Phase 3-ready) and TPST-
SAN JOSE, Calif. , Nov. 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
FAULKNER COLLISION CENTER OF LANCASTER AND MANAGER APRIL LAUSCH HONORED WITH NATIONAL I-CAR AWARDS
05:32pm, Wednesday, 05'th Nov 2025
/PRNewswire/ -- I-CAR (the Inter-Industry Conference on Auto Collision Repair) proudly recognized the outstanding achievements of this year's industry award
Avis Budget Stock Declines 11% Despite Reporting Q3 Earnings Beat
02:31pm, Wednesday, 05'th Nov 2025
CAR's third-quarter 2025 earnings and revenues top estimates, yet the stock slides 11% as investors react to mixed segmental results.
Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with longer-ter
Y Intercept Hong Kong Ltd Makes New $1.30 Million Investment in Avis Budget Group, Inc. $CAR
03:42am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd bought a new position in Avis Budget Group, Inc. (NASDAQ: CAR) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
BERKELEY, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that it will hol
Car-Mart delayed its annual report, restated results over loan modification issues, and later reported weak Q1 sales, causing significant stock declines.
CAR Group Limited (CSXXY) Shareholder/Analyst Call Transcript
02:26pm, Friday, 31'st Oct 2025
CAR Group Limited (OTCPK:CSXXY) Shareholder/Analyst Call October 30, 2025 8:01 PM EDT Company Participants Patrick Redmond O'Sullivan William Elliot - MD, CEO & Director Nicole Birman - General Counse
